Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia. - Wikidata - wikimedia - TriplyDB

Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia.

Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia.

http://www.wikidata.org/entity/Q41933891

about

Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices Composite scaffold provides a cell delivery platform for cardiovascular repair."Second-generation" stem cells for cardiac repair Body Management: Mesenchymal Stem Cells Control the Internal Regenerator.Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study.Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.Adipose-derived stem cells promote angiogenesis and tissue formation for in vivo tissue engineering.Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study.Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?An update on stem cell therapies for acute coronary syndrome.Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.Cellular Therapy for Heart Failure.Allogeneic mesenchymal precursor cells (MPCs): an innovative approach to treating advanced heart failure.Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial Prospect of stem cell conditioned medium in regenerative medicine.Bone marrow mesenchymal stem cell‑derived extracellular vesicles improve the survival of transplanted fat grafts.The Use of Biocompatible Alginate Scaffolds Covalently Modified with Cyclic RGDfK Peptides to Improve Survival of Transplanted Cells and Angiogenesis in Damaged Myocardium.Allogeneic cell therapy manufacturing: process development technologies and facility design options.

P2860

Q28073078-C45FEFF1-6586-49B7-9407-0171DFF7035C Q34412796-12896A68-ABF5-4572-BAF3-EED172C06241 Q34977853-C07D016A-2E8A-4003-B584-551852374C69 Q35205665-3C35F3DD-BE0F-4D9C-80B1-EDCC750EFD6F Q35777526-41C4C7C0-29A5-4ECE-B071-2265F0898C43 Q35973271-13C6DD2D-51C2-4DAD-95A8-12C4AC393135 Q36233665-29743FEA-1323-45C7-B95F-359F3562BE92 Q36801523-933C8858-1B1E-4A64-BD2D-0FCB45CFBF8D Q37363555-6606B4C1-F15C-47EC-A2F0-536D82812C55 Q38114405-AC35C712-0CCE-4C99-8C49-BA2F085FD0F4 Q38235169-C38A65CB-C6D5-4BD2-B27F-42DA779096FB Q38608414-F52CC131-F2EC-4ADF-A2F2-92F930D4DE67 Q38859871-64A93AF3-1DD1-465F-A536-69EB92FAF0D5 Q38885298-84CA9A5B-68C1-42C1-A39D-61EC4A368C9C Q40097844-FAE87778-1E19-4F26-9F86-6A63D2F60AEB Q41660528-1E036B61-92D5-486D-8B46-9EF6BBFFF648 Q42546736-D7EAE283-B450-404E-8318-41CE04ADE966 Q48653172-071A713F-689A-4B8B-928A-6D6FCF9D8D7A Q50432799-F3F70466-71AF-464F-BCDE-9DF7FD8DCB0F

P2860

Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemia.

http://www.wikidata.org/entity/Q41933891

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Therapeutic effects of human S ...... erimental myocardial ischemia.

@en

type

label

Therapeutic effects of human S ...... erimental myocardial ischemia.

@en

prefLabel

Therapeutic effects of human S ...... erimental myocardial ischemia.

@en

P1433

Q41933891-D7D42911-3A2A-41A7-9087-46FC5D53E583

P1476

Q41933891-149F2E76-DB9E-4C08-89D5-84BC50BBBAC3

P2093

Q41933891-096502B3-26A7-4BFE-A20E-2BD375E9101A

Q41933891-0BB4216C-B970-4B64-8895-B9BAF5E54DA1

Q41933891-0FBA74F9-6713-4A36-B3D5-4815D3B4D2AB

Q41933891-20AA3054-A836-4EE4-BC63-A4F4BB2BF222

Q41933891-3A6747D2-4F86-4D6C-9B6D-B51314DE787B

Q41933891-6128BA9B-1D19-4D6F-B797-9E3874C10BC2

Q41933891-8A47630E-9ECB-457E-A933-32803C8B6A1C

Q41933891-C3F198BF-5BF2-4FB3-8B6B-BDDBFEAFD0EA

Q41933891-E7E67B26-E2A0-4BDF-AFBF-4CAB76E5BB4E

Q41933891-F7B15325-BB0E-4212-950A-B31FA003EB6F

P2860

Q41933891-0D2200E3-3305-4E32-AD9A-17396C5B05E9

Q41933891-153BB959-ED2F-466F-BC86-B10B46EDFD7A

Q41933891-26B5658C-2CE0-44AE-9AAA-93395A552D7D

Q41933891-40FD5FB1-0493-41DD-9AF5-E132BEC36BD0

Q41933891-4BB5E405-31B8-4D19-80D4-94143733AD01

Q41933891-4D99333C-660C-4329-954E-79C4182401A5

Q41933891-52A9236B-CA26-4414-9205-0BCADEB5300A

Q41933891-55BC5637-6053-4BDF-91EB-48A45006F92B

Q41933891-5855412A-3048-4765-9350-05CED9A91C17

Q41933891-59394D1A-846D-4404-9E6D-1C4B67E108D3

P304

Q41933891-5B90A743-EA61-4D4A-AB83-66EE112D5635

P31

Q41933891-602A6B95-5C46-4C0E-9D5B-210E80457C1D

P356

Q41933891-B04D7527-BCE7-40DB-A29C-1051E9461087

P433

Q41933891-E12C8679-BC25-4EE8-AD60-5320EFB071AE

P478

Q41933891-8621A323-FC5A-4287-A39D-F8347D985562

P50

Q41933891-5CD292E5-21D8-44A0-890A-EA0B2CAE36CA

Q41933891-83F4061D-9F0F-462B-891C-EBE13D5DF01C

P577

Q41933891-F6F739AA-85F2-4635-8E45-9908BA3B9E4A

P5875

Q41933891-1233F076-D0B7-4778-B9A5-3699AF17D241

P698

Q41933891-CF408123-3CCA-4BA3-92A3-E9F0E42597B5

P932

Q41933891-31A26DB5-B3A6-459B-8D9F-9176EE214436

P356

J.1582-4934.2010.01241.X

P1433

Journal of Cellular and Molecular Medicine

P1476

Therapeutic effects of human S ...... perimental myocardial ischemia

@en

P2093

Darren J Kelly

http://www.w3.org/2001/XMLSchema#string

Fiona See

http://www.w3.org/2001/XMLSchema#string

Henry Krum

http://www.w3.org/2001/XMLSchema#string

Hugo P Sondermeijer

http://www.w3.org/2001/XMLSchema#string

Klaas M Govaert

http://www.w3.org/2001/XMLSchema#string

Michael D Schuster

http://www.w3.org/2001/XMLSchema#string

Paul A Kurlansky

http://www.w3.org/2001/XMLSchema#string

Peter J Psaltis

http://www.w3.org/2001/XMLSchema#string

Silviu Itescu

http://www.w3.org/2001/XMLSchema#string

Tetsunori Seki

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Multilineage potential of adult human mesenchymal stem cells

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Bone marrow cells regenerate infarcted myocardium

Human mesenchymal stem cells modulate allogeneic immune cell responses

Human and rodent bone marrow mesenchymal stem cells that express primitive stem cell markers can be directly enriched by using the CD49a molecule

Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair

Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities.

Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.

Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage.

P304

2117-2129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1582-4934.2010.01241.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Zannettino

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227941820

http://www.w3.org/2001/XMLSchema#string

P698

21155976

http://www.w3.org/2001/XMLSchema#string

P932

3092801

http://www.w3.org/2001/XMLSchema#string